These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 30503888)
1. Establishment of a lethal aged mouse model of human respiratory syncytial virus infection. Zhang K; Li C; Luo YS; Wen L; Yuan S; Wang D; Ho-Yin Wong B; Zhao X; Chiu MC; Ye ZW; Sun Z; Zhao H; Zhang X; Hu M; Yang D; Shuai H; Wang Y; He J; Bose ME; Henrickson KJ; Huang JD; Zheng B; Chu H; Zhou J Antiviral Res; 2019 Jan; 161():125-133. PubMed ID: 30503888 [TBL] [Abstract][Full Text] [Related]
2. Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644 [TBL] [Abstract][Full Text] [Related]
3. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice. Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474 [TBL] [Abstract][Full Text] [Related]
4. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy. Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294 [TBL] [Abstract][Full Text] [Related]
5. The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse. Xu ML; Kim HJ; Wi GR; Kim HJ J Microbiol; 2015 Sep; 53(9):661-6. PubMed ID: 26310306 [TBL] [Abstract][Full Text] [Related]
7. Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo. Liu Q; Lu L; Hua M; Xu Y; Xiong H; Hou W; Yang Z J Ethnopharmacol; 2013 Nov; 150(2):521-8. PubMed ID: 24051026 [TBL] [Abstract][Full Text] [Related]
8. Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach. Aljabr W; Touzelet O; Pollakis G; Wu W; Munday DC; Hughes M; Hertz-Fowler C; Kenny J; Fearns R; Barr JN; Matthews DA; Hiscox JA J Virol; 2016 May; 90(10):4876-4888. PubMed ID: 26656699 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models. Van den Berg J; Kwanten L; Roymans D Methods Mol Biol; 2013; 1030():365-72. PubMed ID: 23821282 [TBL] [Abstract][Full Text] [Related]
10. Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A. Rahman F; Libre C; Oleinikov A; Tcherniuk S J Gen Virol; 2021 Aug; 102(8):. PubMed ID: 34342560 [TBL] [Abstract][Full Text] [Related]
11. Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection. Bohmwald K; Gálvez NMS; Canedo-Marroquín G; Pizarro-Ortega MS; Andrade-Parra C; Gómez-Santander F; Kalergis AM Front Immunol; 2019; 10():452. PubMed ID: 30936869 [TBL] [Abstract][Full Text] [Related]
12. Anti-viral activity of water extract of Paeonia lactiflora pallas against human respiratory syncytial virus in human respiratory tract cell lines. Lin TJ; Wang KC; Lin CC; Chiang LC; Chang JS Am J Chin Med; 2013; 41(3):585-99. PubMed ID: 23711143 [TBL] [Abstract][Full Text] [Related]
13. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells. Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966 [TBL] [Abstract][Full Text] [Related]
14. Establishment and application of a lethal model of an HRSV-long variant strain in BALB/c mice. Li H; Ren H; Cao L; Guo J; Song J; Zhang Y; Xu W Exp Anim; 2022 Nov; 71(4):500-509. PubMed ID: 35732419 [TBL] [Abstract][Full Text] [Related]
16. Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication. Bailly B; Richard CA; Sharma G; Wang L; Johansen L; Cao J; Pendharkar V; Sharma DC; Galloux M; Wang Y; Cui R; Zou G; Guillon P; von Itzstein M; Eléouët JF; Altmeyer R Sci Rep; 2016 May; 6():25806. PubMed ID: 27194388 [TBL] [Abstract][Full Text] [Related]
17. Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo. Sudo K; Watanabe W; Mori S; Konno K; Shigeta S; Yokota T Antivir Chem Chemother; 1999 May; 10(3):135-9. PubMed ID: 10431613 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants. Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081 [TBL] [Abstract][Full Text] [Related]
19. Contribution of NKT cells to the immune response and pathogenesis triggered by respiratory viruses. Rey-Jurado E; Bohmwald K; Gálvez NMS; Becerra D; Porcelli SA; Carreño LJ; Kalergis AM Virulence; 2020 Dec; 11(1):580-593. PubMed ID: 32463330 [TBL] [Abstract][Full Text] [Related]
20. CD8+ T cell immunity against human respiratory syncytial virus. Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]